Business

Indian Equity Market Update and Corporate News

Monday, May 25, 2026
5 min read
Indian Equity Market Update and Corporate News

The Indian equity market is looking up this week. There’s a real gap-up expected, with Gift Nifty already ticking over 270 points, up about 1.15 percent in the morning session. People are hoping this positive momentum keeps going, tied up in those ongoing Iran-US war negotiations.

Crude oil prices took a hit on Monday, falling sharply. That’s because the US and Iran moved closer to some kind of deal that would finally reopen the Strait of Hormuz. That kind of uncertainty always rattles things.

Some stocks are getting attention for different reasons right now.

Over in the corporate shuffle, things are moving around the indices. The FTSE is adding a few names, like Tata Capital , Lenskart Solutions , LG Electronics , Meesho , ICICI Prudential Asset Management Company , and Billionbrains Garage Ventures (Groww) to the FTSE All World and FTSE All Cap lists starting June 22nd.

Meanwhile, the NSE is making some moves too. They’re removing Exide Industries and Nuvama Wealth Management from the Futures & Options segment, effective July 29th.

The Sensex and BSE 100 are seeing some big swaps happening. TVS Motor Company is going to replace Adani Enterprises in the Sensex 50 . That’s one move.

But there’s a bigger shift happening with the BSE Sensex Next 50 . Adani Enterprises , Ashok Leyland , One 97 Communications (Paytm) , and CG Power and Industrial Solutions are entering it. They’re swapping out TVS Motor , Ambuja Cements , Colgate Palmolive , and Tube Investments of India .

And then there are the adjustments to the main 100 index. Ashok Leyland , One 97 Communications , and CG Power are getting added to the BSE 100 . Ambuja Cements , Tube Investments , and Colgate Palmolive are getting dropped. All these index changes kick in June 22nd.

On the pharma side, Aurobindo Pharma just got that OAI status from the US FDA. They said the inspection of their Telangana facility, done between February 16 and 27, resulted in Official Action Indicated. Four observations came out of that inspection.

Across the border, Lupin is making a move into China. They got the Green light from the Chinese regulator for their Oseltamivir Phosphate Oral Suspension . It’s a paediatric drug for the flu, and this marks their entry into that market.

Wipro also fixed the record date for their share buyback. It’s set for June 5th, for that Rs 15,000 crore program.

The Central Bank of India’s offer-for-sale saw some serious interest on Day 1. Non-retail investors were really active, subscribing 2.36 times the shares offered. And the bank is going to exercise the oversubscription option for an extra 4% stake sale, which bumps up the total offer size.

RBL Bank is also in the spotlight, especially after Emirates NBD put out an open offer. They’re looking at acquiring up to a 26% stake in RBL Bank for about Rs 11,735 crore. The price tag is Rs 282.38 per share.

Indian Railway Finance Corporation , or IRFC , is also seeing some movement. They signed a $1.1 billion External Commercial Borrowing aGreement with a group of banks, including SBI , HDFC Bank , Sumitomo Mitsui Banking Corporation , and DBS Bank . That development is likely to keep the IRFC share price in focus today.

Separately, Gujarat Themis Biosyn announced they’re buying something from Japan. Their subsidiary, Themis Biosyn Japan , is going to acquire MicroBiopharm Japan , a deal worth roughly Rs 1,300 crore. Just another piece of the puzzle moving along.

Written by Gree News Team — Senior Editorial Board

Gree News Team covers international news and global affairs at Gree News. Our collective of senior editors is dedicated to providing independent, accurate, and responsible journalism for a global audience.

#sensational#business#global#trending

More from Business

View All

Latest Headlines